The One Thing Vets Wish All Dog Owners Understood first appeared on Parade Pets on Jun 28, 2025 This story was originally ...

A young woman’s dog was the first to detect her deadly breast cancer. In June 2023, Breanna Bortner, then 30, noticed her cockapoo Mochi became fixated on her right breast; sniffing, pawing and ...

If you’re looking for the best liver supplements for dogs, we’ve got you covered! Liver problems in dogs can show up as loss of appetite, weight loss, excessive thirst, and urination. Liver ...

The full Monty: When dog and owner are both battling cancer - opinion For both of us, a sinister countdown had started. By BRIAN BLUM MAY 18, 2025 22:08 ...

Hepatitis B virus (HBV) infection is known to be associated with the risk of hepatocellular carcinoma (HCC), but how and why ...

Breanna Bortner’s dog, Mochi, began fixating on her breast before she was diagnosed with stage 2B triple-negative breast cancer, showing unusual and intuitive behavior throughout her journey.

Yaffe was diagnosed with cancer when she was 20. “I went to a doctor over the summer, who knew me personally, and she felt around my whole body. She even felt my liver and she didn’t feel ...

Possible Ivermectin Contraindications. Unfortunately, not much information is available on this for several of those medications in dogs. In human medicine, we do know that some drugs are ...

But recent statistics highlight the importance of prioritising your liver health. New analysis by Cancer Research UK revealed that the number of people dying from liver cancer has almost doubled in ...

If your dog has some symptoms of liver problems, your vet may ask you about their diet and medications. The vet may want to do blood tests and X-rays or an ultrasound to get a picture of what is ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has emerged as a heterogenous disease tightly linked to metabolic dysfunction ...

Co-invented by Karmanos Cancer Institute President and CEO Boris Pasche, MD, PhD, the TheraBionic P1 uses radiofrequency electromagnetic fields at specific frequencies to target liver cancer tumors.